Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cholesterol-dependent pathway in *Mycobacterium tuberculosis* (Mtb) refers to the bacterium’s ability to acquire, metabolize, and utilize host-derived cholesterol as a critical nutrient source during infection. This pathway is essential for Mtb survival, persistence within host macrophages, and pathogenesis. It involves cholesterol uptake via the Mce4 transporter and host receptors, catabolism via enzymes like cytochrome P450s and sterol-CoA ligase, and regulation by transcriptional factors like KstR and KstR2. Targeting this pathway offers potential therapeutic strategies by inhibiting bacterial acquisition/metabolism or reducing host cell cholesterol levels.
Inhibition of cholesterol uptake or catabolic enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholesterol-Dependent Pathway in Mycobacterium tuberculosis.